RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

Clinical trials for RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Last-Hope drug offered to patients with aggressive lymphoma

Disease control AVAILABLE

This program provides access to an experimental drug called odronextamab for people with advanced B-cell lymphomas that have come back or stopped responding to standard treatments. It is for patients who have run out of approved treatment options. The goal is to control the cance…

Matched conditions: RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

Get alerted when new RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) trials appear

Last-Hope drug offered to patients with aggressive lymphoma